For the efficient stimulation of T cells by tumor Ag, tumor-derived material has to be presented by dendritic cells (DC). This very likely involves the uptake of dead tumor cells by DC. Cell death in tumors often occurs through apoptosis, but necrotic cell death may also be prevalent. This distinction is relevant because numerous studies have proposed that apoptotic cells have immunosuppressive effects while necrosis may be stimulatory. However, a system has been lacking that would allow the induction of apoptosis or necrosis without side effects by the death stimuli used experimentally. In this study, we present such a system and test its effects on immune cells in vitro. B16 mouse melanoma cells were generated and underwent cell death through the doxycyclineinducible induction of death proteins. In one cell line, the induction of Bim S induced rapid apoptosis, in the other line the induction of the FADD death domain induced nonapoptotic/necrotic cell death. Bim S -induced apoptosis was associated with the typical morphological and biochemical changes. FADD death domain induced necrosis occurred through a distinct pathway involving RIP1 and the loss of membrane integrity in the absence of apoptotic changes. Apoptotic and necrotic cells were taken up with comparable efficiency by DC. OVA expressed in cells dying by either apoptosis or necrosis was cross-presented to OT-1 T cells and induced their proliferation. These results argue that it is not the form of cell death but its circumstances that decide the question whether cell death leads to a productive T cell response.
T he immune system is an important line of defense against tumors. Many self, altered self, and foreign (especially viral) tumor Ags can be recognized by the immune system (1) . This recognition is thought to be relevant to the prevention of tumor development (although this view has been challenged for some cases (2) ) and many attempts are being made to harness this potential of the immune system to attack established tumors. One major issue of immune recognition of tumors is the way by which tumor Ag is made available to the immune system and how Ag recognition leads to a productive response of the adaptive immune system.
Peptides derived from tumor Ags presented by the tumor cell's MHC molecules are very likely insufficient to activate naive T cells because additional stimulatory signals are usually lacking. As tumor cell-associated Ags, however, tumor Ags can be made available to the immune system through the uptake and processing of tumor cells by APCs (3) . It is clear that not only macrophages but also dendritic cells (DC) 4 can take up dead cells, and because cell death is a frequent event in tumors, the uptake of material from dead cells by APC and the subsequent presentation to T cells is likely a major way by which tumor Ag is made available to the immune system. It is therefore an important goal to understand how this recognition is achieved and what signals determine T cell stimulation through DC that have taken up dead tumor cells. Over the past years, many studies have suggested that the form of cell death is one such determinant (7) (8) (9) (10) (11) (12) (13) (14) .
Cell death can occur either through the activation of the apoptotic signaling pathway or through other mechanisms that may or may not involve an active participation of the dying cell (4, 5) . Although distinctions within this latter group have been made, most authors prefer to use the term necrosis to describe all nonapoptotic cell death (6) . One feature of apoptosis is the relatively long integrity of the plasma membrane and the rapid uptake by phagocytes. These events may occur at different kinetics during necrosis. Apoptosis is therefore generally understood as a silent form of cell death, in that the intact cell disappears through phagocytic uptake without the release of proinflammatory stimuli (7) . A number of in vitro findings support this view, especially the secretion of anti-inflammatory cytokines (IL-10, TGF␤) from macrophages upon the uptake of an apoptotic cell (8) . Necrosis, in contrast, is usually accompanied by an earlier breakdown of plasma-membrane integrity, which may permit the leakage of proinflammatory cellular components (7) .
However, more recent work has challenged the simple dichotomy of apoptosis and necrosis as anti-and proinflammatory, or immunosuppressive and immunostimulatory. For instance, infection with influenza virus has been found to induce apoptotic cell death in infected macrophages, but a productive T cell stimulation following uptake of the apoptotic cells by DC was detected (9) . Similar observations have been made during infection with Salmonella (10) . Recently it was shown that the injection of apoptotic cells into mice could elicit a productive T cell response that involved type I IFN production by FLT3-ligand-derived DC (11) . The view that necrosis always is immunostimulatory (12) is also not unchallenged; some authors have even suggested that at least part of the immunostimulation described may have been due to microbial contamination (13) . Taken together, the available information thus suggests that the circumstances surrounding cell death (such as cell types involved and proinflammatory stimuli present) play a substantial role in the decision of whether the uptake of dead cells causes a productive immune response or not.
Another level of complexity is added by the different modes of cell death induction that are used either experimentally or that are suspected to operate in vivo. Apoptosis can be induced by multiple stimuli, and although cell death by apoptosis is implemented by a common pathway (at least in its final phase), commonly used apoptosis stimuli are bound to produce multiple side effects besides apoptosis-induction in the cells used. Examples of such side effects in commonly used apoptotic stimuli include activation of stress kinases (by UV irradiation), inhibition of kinases (staurosporine), and a DNA damage-response (UV light, etoposide, and many others). Similarly, the experimental induction of necrosis is usually achieved by freezing and thawing cells. Perhaps this reflects, to a degree, necrosis caused by acute tissue injury, but it is at the same time bound to introduce uncontrollable secondary effects such as loss of proteins and organelles, as well as aggregation and degradation of components. A recent study used ganciclovir to induce apoptosis and a vascular targeting compound to induce necrosis in vivo (14) . However, even in this approach it is far from clear that these components exclusively induced these forms of cell death and that they had no additional effects on the dying cell and on the immune system.
We undertook this study to establish a model system where apoptosis or necrosis can be induced by minimal manipulation in the same cell type. By tetracycline (tet)/doxcycline-inducible expression of the proapoptotic Bcl-2 family (BH3-only) protein Bim S , mitochondrial apoptosis was induced rapidly and efficiently. By expression and dimerization of the Fas-associated death domain protein (FADD/MORT1), necrosis could be induced. The generation of derivatives of the mouse melanoma B16 expressing these proteins permitted the analysis of the events of cell death in the same cell type as well as the events subsequent to recognition of dead cells by DC.
Materials and Methods

Cell lines and cell culture
The mouse melanoma cell line B16 was maintained in DMEM (Biochrom) supplemented with 10% FCS (tet negative, PAA Laboratories), 50 g/l penicillin/streptomycin, 50 M 2-ME, and 50 g/ml G-418 sulfate.
Tet/doxycycline-inducible expression of Bim S or FADD death domain (FADD-DD) is based on the ViraPower T-REx Lentiviral Expression System (Invitrogen). B16-TREx cells stably expressing the TetR were generated by lentiviral transduction of pLenti6/TR, followed by selection with 5 g/ml blasticidin. To generate a tet-inducible Bim S -expressing cell line for direct apoptosis induction, mouse Bim S was cloned into pLenti4/TO/V5-DEST. Because lentiviral transduction of Bim S into B16-TRex cells gave no success, a stable cell line was generated by transient transfection and selection in the presence of 2 g/ml zeocin (Invitrogen). For direct induction of necrosis, the death domain of human FADD was fused to the C terminus of three copies of gyrase B from E. coli, allowing coumermycin (CM)-mediated dimerization of the fusion protein (15, 16) . The construct, including an N-terminal Flag-tag, was cloned into pLenti4/TO/V5-DEST. Upon lentiviral transduction of the pLenti4/TO/3xGyr-FADD-DD construct into B16-TREx cells, single clones were selected in the presence of 2 g/ml zeocin. Cell lines were maintained in selection medium unless stated otherwise.
B16-Ova-Bim S and B16-Ova-FADD-DD cell lines were generated by retroviral transduction of the OVA cDNA cloned into the MIGR1 vector. Internal ribosomal entry site-driven translation of GFP allowed selection of polyclonal GFPϩ cell lines by FACS sorting. The DC line D2SC1 was maintained in complete RPMI 1640 (RPMI 1640 containing 10% FCS, 50 g/l penicillin/streptomycin, and 50 M 2-ME). To induce gene expression or dimerization, cells were stimulated with 1 g/ml tet (Invitrogen) or 1 M CM (Sigma-Aldrich) as indicated. The necrosis inhibitor necrostatin-1 (Sigma-Aldrich) was used at a concentration of 50 M as indicated.
Generation of mouse bone marrow derived DC (BMDC)
BMDC were differentiated from mouse bone marrow from C57BL/6 mice according to standard protocols. Bone marrow cells (5 ϫ 10 6 ) were cultured in medium supplemented with 10% supernatant from a GM-CSF producing cell line. On day 3 of culture, another 10 ml of medium containing GM-CSF was added. On day 6 to 8, cells were harvested and used for experiments.
Cell death assays
Assay for plasma membrane integrity (propidium iodide (PI) staining). Cell death as determined by loss of plasma membrane integrity was measured by addition of PI (5 g/ml) to unfixed cells. Analysis of PI-positive cells was performed on a FACSCalibur (BD Biosciences). Assay for nuclear apoptosis (Hoechst staining). For assessment of nuclear morphology, cells were stained with 1 g/l Hoechst 33342 dye (SigmaAldrich) for 30 min at 37°C, harvested, washed with PBS, and resuspended in PBS. Nuclei were examined using an epifluorescence microscope (Zeiss). AnnexinV/PI staining. Cells were labeled with annexin V-FITC (Invitrogen) according to the manufacturer's instructions, costained with PI, and analyzed by flow cytometry.
Western blot analysis
Cells were washed once in PBS and harvested in extraction buffer (1% NP40, 20 mM Tris-HCl pH 8.8, 10 mM NaCl, 1 mM EDTA) supplemented with complete proteinase inhibitor mixture (Roche). Nuclei and cellular debris were pelleted by centrifugation at 2000g for 10 min at 4°C. Aliquots of the supernatants were used for determination of protein concentration (Bio-Rad assay). In some cases cells were directly lysed in 1ϫ Laemmli buffer. Supernatants were boiled in Laemmli buffer and equal amounts of protein were resolved on 12.5% acrylamide gels by SDS-PAGE and transferred on nitrocellulose membranes. Equal protein loading was confirmed by reprobing with anti-␤-actin Ab (Sigma-Aldrich). Membranes were probed with Abs specific for Bim (Sigma-Aldrich), FADD (BD Biosciences), caspase-9, poly(ADP-ribose) polymerase (PARP) (both from New England Biolabs), active caspase-3, or OVA (both from Abcam). Secondary HRP-conjugated anti-rabbit or anti-mouse IgG Abs were obtained from Sigma-Aldrich and Dianova. Blots were developed using an ECL detection system (PerkinElmer).
Electron microscopy
Cells were harvested and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4; Electron Microscopy Sciences) and embedded in epoxy resin (Epon 812; Electron Microscopy Sciences). Ultrathin sections were examined with an EM 10 CR transmission electron microscope (Zeiss).
In vitro uptake of dying B16 cells by BMDC
Before cell death induction and coculture, B16-Bim S or B16-FADD-DD cells were labeled with the green fluorescent cell linker PKH67 (SigmaAldrich) according to the manufacturer's instructions. Following Bim S or FADD-DD induction, B16 cells were harvested, washed with PBS, and 1 ϫ 10 5 cells were then cocultured with 1 ϫ 10 5 DC (D2SC1 or GM-CSF BMDCs) in a 96-well plate in a total volume of 200 l complete RPMI 1640 for 24 h. D2SC1 DC were labeled red before coculture using the PKH26 cell linker, while GM-CSF BMDC were left unlabeled. In case of GM-CSF BMDC, DC were identified by surface staining of cocultures with a PE-labeled anti-CD11c Ab (BD PharMingen) for 30 min on ice after blocking unspecific Ab binding with a Fc ϩ RII/III Ab (BD PharMingen). Uptake was measured by flow cytometry.
Analysis of DC surface marker expression
BMDC (2 ϫ 10 5 cells) were coincubated with B16-Bim S -or B16-FADD-DD-induced cells at a 1:1 ratio. Coculture was performed for 24 h at 37°C in a 50-mm petri dish with 3 ml complete RPMI 1640 containing 10% GM-CSF. For analysis of surface expression of maturation markers, cells were costained with anti-CD11c-APC (1:200) and either anti-CD86-PE (1:100, eBioscience), or anti-CD40-PE (1:100, eBioscience) Ab for 30 min on ice after blocking unspecific Ab binding with a Fc ϩ RII/III Ab (BD PharMingen). Cells were analyzed by flow cytometry.
In vitro OT-1 proliferation assay
For the isolation of OT-I T cells, single-cell suspensions were prepared from the spleen of an OT-I TCR-transgenic mouse. T cells were negatively selected using the Miltenyi MACS Purification Kit (Miltenyi Biotech). Following RBC lysis, B and NK cells were labeled with FITC-coupled Abs (anti-B220, anti-MHC-II, and NK1.1; BD Biosciences), followed by anti-FITC Abs coupled to magnetic beads. Labeled cells were removed by passage over a MACS column (Miltenyi Biotech). For CFSE labeling of isolated OT-I CD8 ϩ T cells, cells were washed twice with 5 ml PBS and incubated with 5 M CFSE (in 1 ml PBS) for 10 min at 37°C. Reaction was blocked with 5 ml RPMI 1640 and cells were placed on ice in the dark for 5 min. Cells were then washed three times with 5 ml PBS, counted, and seeded at 1 ϫ 10 5 cells/well in a 96-well round-bottom plate in RPMI 1640 containing 10% GM-CSF and IL-2 (10 U/ml). BMDC (2.5 ϫ 10 4 cells/ well) were added to the OT-I T cells, and B16-Ova-Bim S or B16-Ova-FADD-DD cells (tet-treated or -untreated) were then harvested, washed in PBS, and added to the coculture of OT-I CD8 ϩ T cells and BMDC at a density of 10 4 cells/well. The coculture was incubated for 3 days at 37°C in a total volume of 250 l containing GM-CSF and IL-2. Upon harvest, cells were stained with anti-mouse CD8␣-APC Ab (Invitrogen) to identify OT-I CD8 ϩ T cells and analyzed by flow cytometry.
Results
We used the mouse melanoma line B16 as the basis of these experiments. B16 cells derive from C57BL/6 mice and have been used in numerous tumor immunology studies in mice. B16 cells were generated that stably express the tet-repressor silencing any tet-dependent promoter. Using these tet-repressor cells, two separate cell lines were made to allow the induction of either apoptosis or necrosis. To induce apoptosis, we placed the potent BH3-only protein Bim S under the control of the tet-repressor and generated a polyclonal line stably carrying the plasmid by antibiotic selection. We have recently described the mode of apoptosis induction by Bim S in HeLa cells in a similar system in detail (17, 18) . Upon transcriptional induction, Bim S translocates to mitochondria where it recruits Bax, which leads to the release of cytochrome c and the subsequent activation of caspase-9 and caspase-3, followed by the typical morphological signs of apoptosis (17) (the pathway is outlined in Fig. 1A ). B16-Bim S cells showed normal growth in culture (cell growth was measured by comparing density of maternal or B16-Bim S cells in parallel cultures that were split multiple times over several weeks. No difference was detectable). No signs of elevated spontaneous cell death were detected either by morphology or by PI staining in B16-Bim S cells either continuously growing in culture or when seeded for a 24 h experiment without treatment (data not shown). However, B16-Bim S cells underwent cell death efficiently when tet was added (see below). As mentioned above, there is no unique pathway to necrosis, and different instances of phenotypical necrosis (cell death in the absence of signs of apoptosis) is likely to have varying molecular causes. As far as we know, the only necrotic pathway that has been characterized in some parts involves the components of the death receptor signaling machinery. This pathway was first described in Jurkat human T cells that had lost caspase-8. In these cells, fas signaling could not cause apoptosis but induced a nonapoptotic cell death instead (19) . In primary T cells, this pathway involves the signaling molecules FADD and RIP1 (20) . Considerable work has been performed in L929 fibroblasts where a similar pathway was shown to operate (21, 22) ; RIP1 plays an indispensable role also in those cells (23) . Although many details of the pathway are still uncertain, FADD-dependent RIP1-activation therefore appears at present to be the only clear way of inducing necrosis through intracellular protein signaling.
This signaling of FADD-RIP1 has been further explored in fibroblasts, and it was found that the expression of individual domains of FADD can either induce apoptosis (the FADD death effector domain, via activation of caspase-8) or necrosis (the FADD-DD), very likely via its binding to RIP1 (24) . In this system, experimental forced dimerization of FADD-DD was used for necrosis induction in L929 fibroblasts (although the requirement of dimerization was not actually tested (24) ). To achieve dimerization in B16 cells, we fused human FADD-DD to the C terminus of bacterial gyrase B and placed this construct under the control of the tet-inducible promoter in B16 cells. Gyrase B can be experimentally dimerized by the dimeric antibiotic CM, which also causes the dimerization of the fusion partner (15, 16, 25) . The strategy is schematically shown in Fig. 1B . As detailed below, expression of this construct induced cell death in B16 cells. Western blotting showed the induction of Bim S or FADD-DD in the engineered cells upon addition of tet (Fig. 1C) .
The addition of tet induced strong morphological changes in both cell lines although with a somewhat faster time course in B16-Bim S cells compared with B16-FADD-DD cells (supplemental Figs. S1 and S2 5 ). By phase contrast, B16 cells dying due to expression of Bim S showed the typical blebs and apoptotic bodies commonly seen during apoptosis (Figs. 2 and S1 ), as well as cellular shrinkage, another typical feature of apoptosis (Fig. S3) . In contrast, B16-FADD-DD cells showed predominantly rounding and detachment from the dish but lesser changes to the cell surface 5 The online version of this article contains supplemental material. and no clear disintegration into apoptotic bodies (Figs. 2 and S2 ). There was no cell shrinkage detectable by flow cytometry (Fig.  S3 ). Chromatin staining with Hoechst dye revealed pyknosis and karyorrhexis in B16-Bim S cells, typical signs of apoptosis (Figs. 2 and S1B and data not shown). Although nuclear structural changes were seen in B16-FADD-DD cells, these changes were limited to chromatin condensation around the nuclear perimeter (Figs. 2 and  S2B ). Such changes can also be seen during apoptosis. They appeared incomplete however in the case of B16 cells upon expression of FADD-DD (see also electron microscopy, below). The Bim S -induced nuclear fragmentation was rapid, with ϳ60% of cells displaying apoptotic nuclei after 6 h (Fig. 3B) . Loss of cell membrane integrity was a markedly slower process, with ϳ20 -30% of PI-positive cells after 6 h (Fig. 3A) . Cell death (membrane permeabilization is the only measure we can use here) induced by tet in B16-FADD-DD cells was less efficient and reached ϳ40% after 24 h (Fig. 3A) .
The exposure of phosphatidylserine (PS) on the outer leaflet of the plasma membrane is considered a specific sign of apoptosis. PS can be detected by staining with the protein annexin V labeled with fluorescent dye. As shown in Fig. S4 , a population of annexin V-single positive cells appeared early during the course of apoptosis-induction by Bim S but not by FADD-DD.
The appearance of sub-G1-nuclei, i.e., cells that take up less PI as the nonapoptotic resting population of cells (2n), is considered a typical occurrence of apoptosis. The molecular background of this change is not clear but is may involve loss of DNA due to DNA degradation or apoptotic condensation, leading to less efficient uptake of the dye. We compared the relative number of sub-G1 cells in populations of cells dying upon expression of either Bim S or FADD-DD. Cells were not permeabilized but stained with PI directly from the culture. By using this approach, we limited the analysis to the cells that had lost plasma/nuclear membrane integrity (dead cells). As shown in Fig. S5 , a substantial subpopulation of these dead cells showed sub-G1-staining in the B16-Bim S cell line, as expected. Some sub-G1 cells were also detectable in the dead cell population in the B16-FADD-DD line, perhaps indicating a small number of apoptotic cells, but the majority retained normal DNA content/staining properties (despite having lost membrane integrity) (Fig. S5 ). This again shows distinct forms of cell death following the expression of either Bim S or FADD-DD in B16 melanoma cells.
Ultrastructural analysis was performed by electron microscopy. As shown in Fig. 4 , tet-treated B16-Bim S cells showed the typical features of apoptosis. B16-FADD-DD cells also exhibited typical features of necrosis, in particular the loss of plasma membrane integrity in the absence of nuclear condensation (Fig. 4) . Some additional features were noted, such as the partial chromatin condensation in some cells (similar to what we had observed by fluorescence microscopy, Fig. 2 ), prominent appearance of the Golgi network, and unusual, large protrusions of the cytosol (Fig. S6) .
We tested for the activation of the apoptotic pathway by Bim S or FADD-DD by analysis of caspase processing and activity. As suggested by numerous studies and as we have shown in HeLa cells, the expression of Bim S can activate the mitochondrial apoptosis pathway, which culminates in the activation of caspase-9 and -3 (17) . A great number of proapoptotic stimuli can activate the same pathway. We used staurosporine as a positive control for apoptosis through the mitochondrial pathway. As shown in Fig. 5 , staurosporine induced the processing of caspase-9 and -3 to yield the expected active fragments. Activity of caspase-3 was further apparent as the cleavage of the caspase-3-substrate PARP. Addition of tet to B16-Bim S cells caused the appearance of clear bands corresponding to the processed proteins (Fig. 5) . Faint but reproducible bands of active caspases were also seen when B16-FADD-DD cells were treated with tet, although the intensity of these bands was very substantially reduced compared with B16-Bim S cells (Fig. 5) . It may be possible that the expression of FADD-DD causes cellular perturbances that can result in apoptosis in a small proportion of the cells, but the majority of cells appeared to be dying in the absence of caspase activation.
A small-molecule inhibitor of necrotic cell death was recently identified and named necrostatin-1 (26) . An analysis into its molecular target identified necrostatin-1 as an inhibitor of RIP1 (27) . Because our model of FADD-DD-induced cell death was based on the assumption that FADD-DD activates RIP1, we tested whether necrostatin-1 could inhibit FADD-DD-induced cell death. As shown in Fig. 6 , necrostatin-1 substantially reduced FADD-DDinduced cell death but had no effect on cell death induced by Bim S (cell death was measured as loss of plasma membrane integrity/ uptake of PI). The expression of FADD-DD therefore very likely activated the pathway to necrosis identified in previous work. The block of necrosis by necrostatin-1 was not complete. This may have been due to incomplete inhibition of the kinase in intact cells. It is, however, also possible that FADD-DD also caused a small amount of apoptosis in the cell population through unknown signaling pathways. This may also be the reason for the observed small processing of caspases (Fig. 5, top panel) .
Surprisingly, CM-induced dimerization of the gyrB-FADD-DD construct was not necessary. In experiments where the concentration of either tet or CM was titrated, no CM-dependent effect was seen (data not shown). It is possible that the 3ϫ gyrB tag we used had some auto-aggregating activity, and we have found evidence for this in a different model recently (15) . It is, however, also possible that oligomerization of FADD-DD is not necessary for RIP1-activation, or that the isolated FADD-DD auto-aggregates. When using full-length FADD, forced dimerization appeared to be required (28) but the necessity of dimerization of FADD-DD has not been tested before. Some of the experiments described below were performed using tet alone.
Because we wanted to have a more sensitive system for Agpresentation and T cell stimulation, the B16 cells described were next modified to express OVA. The ova gene was introduced into B16-OVA Bim S and B16-OVA FADD-DD cells by retroviral transduction. Polyclonal lines were generated, and the internal ribosomal entry site-driven translation of GFP allowed purification of GFP-positive cell populations by cell sorting. Cell lines that were almost completely positive for GFP were obtained (Fig. S7) . These cells expressed ova as established by Western blotting, and expression did not substantially change during cell death induction (Fig. S7) . Cell death induction (PI uptake) was, compared with cells without ova, somewhat reduced in B16-OVA-Bim S cells and very similar in B16-OVA-FADD-DD cells (Fig. S8) . These lines were used to test for Ag uptake and presentation.
When considering the potential of Ag derived from dead cells to stimulate T cells, this process can be broken down into a number of individual steps. The first step in the process is the uptake of dead cells by phagocytes, especially DC, and it has been recently suggested that the efficiency of uptake determines the immunogenicity of tumor-associated Ags (29) . We compared the uptake of B16-OVA-Bim S and B16-OVA-FADD-DD cells by DC upon tettreatment. B16 cells were stained with a green membrane dye, tet-treated, and added to primary BMDC from GM-CSF-culture. Following incubation, cultures were stained with CD11c to identify DC and analyzed by flow cytometry. As shown in Fig. 7 , dead cells were efficiently taken up by DC. It is not easy to quantify this effect because, as shown above, the different forms of cell death are associated with the development of different signs of death with varying time courses. We therefore used the PI uptake of cells before addition of the cells to DC as the measure of cell death. Using this parameter, the data obtained are consistent with the view that cells dying due to Bim S expression are taken up with the same efficiency as cells dying due to signaling of FADD-DD. Similar results were obtained when the DC-like cell line D2SC1 was used instead of primary DC (Fig. S9) . These results suggest that dead cells, irrespective of the form of cell death, are taken up efficiently by DC.
To stimulate T cells effectively, DC have to mature and acquire costimulatory molecules on their surface. In coculture experiments, B16-OVA-Bim S and B16-OVA-FADD-DD cells failed to induce the surface expression of CD86 or CD40 on BMDC (Fig.  S10) . At least during coculture for 24 h, there was therefore no indication of a strong maturation stimulus conveyed by either apoptotic or necrotic cells.
We finally tested whether Ag from cells dying consecutively to expression of Bim S or FADD-DD could be cross-presented by BMDC in vitro. For these experiments, we used a culture system consisting of B16-OVA-Bim S or B16-OVA-FADD-DD cells, BMDC and purified T cells from OT-1 mice (these transgenic T cells express a TCR specific for the ova peptide SIINFEKL on H-2 K b ). OT-1 T cells were labeled with CFSE to trace cell divisions. No proliferation of OT-1 T cells was detectable when B16-OVABim S or B16-OVA-FADD-DD cells were added in the absence of DC (not shown). However, a number of cell divisions could be clearly seen when B16-OVA-Bim S or B16-OVA-FADD-DD cells were killed by tet and added to cocultures of BMDC and OT-1 T cells (Fig. 8) . No OT-1 T cell proliferation was induced where the same B16 lines were coincubated with DC and OT-1 T cells in the absence of tet (not shown). DC in this system were therefore able not only to take up Ag from dying cells but also to cross-present it to T cells, causing their proliferation. Remarkably, no obvious difference between apoptotic and necrotic cells was seen. These results therefore demonstrate a surprising similarity in stimulatory potential of cells that had died by either apoptosis or necrosis where cell death had been induced by direct activation of signaling proteins.
Discussion
In this study we describe models of pure apoptosis and necrosis in B16 mouse melanoma cells. Analysis of cell death demonstrates two distinctive forms of cell death triggered either by Bim S or by FADD-DD. Surprisingly, the mode of cell death seemed not to impact on uptake and presentation of cell-associated Ag by DC or their maturation. The results show the feasibility of inducing distinct forms of cell death in the same cellular background by minimal experimental manipulation and will be useful in separating cell death-associated events from secondary phenomena in models of immunity to cellular Ags.
The detailed understanding of mitochondrial apoptosis that has evolved in recent years makes it possible to directly trigger the release of cytochrome c by the conditional expression of proapoptotic Bcl-2-family proteins. We chose the expression of Bim S because Bim is regarded as the most potent BH3-only protein (30) and the splice variant Bim S is very likely constitutively active while other splice forms (especially Bim EL ) can be highly expressed in healthy cells and may be subject to posttranslational activation. Indeed, in HeLa cells the isolated expression of Bim S was sufficient for the recruitment of Bax to mitochondria, followed by the release of cytochrome c (17) . A more detailed study into the consequences of Bim S expression in those cells showed that a number of apoptosis-linked features, particularly the loss of mitochondrial membrane potential and the loss of plasma membrane integrity, were much slower in cells dying due to Bim S -expression than cells killed by the often used apoptosis-inducers staurosporine and UV light (18) . This finding emphasizes that some links between the apoptotic signaling machinery and downstream postmortem events are incompletely understood and may be relevant to the immunological consequences of cell death. B16 cells dying upon expression of Bim S were taken up efficiently by DC. This was somewhat surprising because a recent study found that, when comparing a number of apoptosis-inducing cancer drugs, some but not all of them were able to induce the uptake of the dead cells by DC (29) . Bim S is very likely a minimal stimulus and is very unlikely to induce additional events, but Bim S -killed B16 cells were taken up efficiently. Perhaps this should be interpreted to mean that the expression of Eat-me signals and uptake is the rule rather than the exception. Some chemotherapeutic drugs may suppress expression of these signals. If necrosis is to be understood as a random process, then by necessity there would be no common signal transduction pathway causing it. However, there must be a molecular cause of necrotic cell death even though it may in some cases simply be caused by physical injury. A number of authors have attempted to solve the problem of possibly different necrosis ways by coining additional terms for some forms of necrotic cell death, such as oncosis (31) , necroptosis (26) , and aponecrosis (32) . The usefulness of such terms is not undisputed (see the recommendations of the Nomenclature Committee on Cell Death (6)). It is a very clear possibility that, immunologically speaking, necrosis may have very different results depending on the precise situation in question, as is indeed likely for apoptosis, despite the common signaling pathway. The only situation where necrosis appears to follow a known sequence of events is the activation of RIP1, which can be initiated by FADD-DD signaling as in the cells we used here.
RIP1 is well-known for its role in activating NF-B in response to TNF-signaling (33) . Pathway and effector mechanisms by which RIP1 induces necrosis are not understood (34) . However, it has been noted a number of times that proapoptotic signaling is converted into RIP-dependent necrosis by inhibition of the apoptotic pathway (34) , and this may well occur frequently in vivo. FADD-DD/RIP1-induced necrosis is therefore a good starting point for the analysis of necrosis-dependent immune stimulation.
Our data indicate that the form of cell death is not the determining factor in the uptake of dead cells. In the nematode C. elegans, it has been found that the uptake of both apoptotic and necrotic cells requires the same genetic program (35) . The uptake of dead cells by professional phagocytes in mammals is likely to be more complex. What the ligands are on apoptotic cells is unclear, and a large number of receptor systems have been shown to contribute, such as collectin receptors, calreticulin/CD91, Fc␥ receptors, c-Mer, the ␤ 2 -glycoprotein I receptor, integrins such as ␣v␤3, lectins, CD14, ABC transporters, scavenger receptors including thrombospondin receptor CD36, and a putative PS receptor (7) . In a model where necrosis was induced by heating the cells to 56 o C, similar receptors were found to contribute previously described for apoptosis (36) . It therefore appears that several receptors can recognize signals on dead cells and initiate the uptake of the dead cell by the phagocyte.
Neither apoptotic nor necrotic B16 cells were able to cause DC maturation as measured by enhanced surface expression of costimulatory molecules. Neither induced IL-6 secretion (not shown) and there was very little type I IFN produced (in five experiments, we could see traces of type I IFN produced by GM-CSF-differentiated DC, always around the detection limit of 15-25 pg/ml. There seemed a tendency towards higher secretion in DC stimulated by B16-Bim S than B16-FADD-DD cells). Perhaps it is surprising that necrotic cells failed to stimulate DC maturation, as this has been demonstrated in the past (using cells killed by freezing and thawing (12) ). However, the validity of that finding has been challenged (13) because FADD-DD/RIP1-induced necrosis in B16 cells failed to cause overt maturation of BMDC, supporting the view that necrosis is at least not necessarily associated with DC-stimulation.
Despite the lack of detectable DC stimulation, ova contained in dying cells was cross-presented to OT-1 T cells, and this signal was sufficient to induce T cell proliferation. OT-1 T cells are notorious for requiring comparatively little costimulation, so little DC maturation is probably sufficient to set them off. It is, however, again remarkable that no obvious difference was found between apoptotic and necrotic cells in terms of immunostimulation or immunosuppression. These data therefore strongly suggest that pure apoptosis and pure necrosis, as induced by the manipulations we have used here, have no or little intrinsic activity to stimulate or to suppress an adaptive immune response. As discussed in the Introduction, the results of how apoptosis and necrosis affect the immune response, which have been obtained in various models of cell death, are extremely contradictory. It can be speculated that the stimulus used and, where present, a proinflammatory context may be important in making the decision whether an adaptive immune response is initiated or not. Our data clearly support a model where cell death per se is innocuous and is mainly important to induce uptake of the antigenic material. Some DC stimulation may occur to the degree that is required to stimulate naive OT-1 T cells. It has to be emphasized that our data are limited to the in vitro situation, and the situation in vivo may be different, especially in a solid tumor where the cells cannot move about freely and the access of APC to cellular material and signals deriving from dead cells may be governed by different principles. However, the context of cell death and uptake, such as the presence of microbederived stimuli or other cellular signaling pathways that are triggered by the death stimulus, may be a far more important factor.
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